No abstract available
Keywords:
G/P; HCV; RAS; Resistance; Retreatment.
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aminoisobutyric Acids
-
Benzimidazoles / administration & dosage*
-
Cyclopropanes
-
Drug Therapy, Combination
-
Female
-
Hepatitis C / drug therapy*
-
Hepatitis C / virology
-
Humans
-
Lactams, Macrocyclic
-
Leucine / analogs & derivatives
-
Male
-
Middle Aged
-
Proline / analogs & derivatives
-
Pyrrolidines
-
Quinoxalines / administration & dosage*
-
Retreatment
-
Sofosbuvir / administration & dosage
-
Sulfonamides / administration & dosage*
-
Sustained Virologic Response
-
Treatment Failure
Substances
-
Aminoisobutyric Acids
-
Benzimidazoles
-
Cyclopropanes
-
Lactams, Macrocyclic
-
Pyrrolidines
-
Quinoxalines
-
Sulfonamides
-
pibrentasvir
-
Proline
-
Leucine
-
glecaprevir
-
Sofosbuvir
Associated data
-
ClinicalTrials.gov/NCT02939989